J Clin Microbiol 2010, 48:4608–4611.PubMedCrossRef 7. The Multilocus Sequence Typing Network [http://​saureus.​mlst.​net/​]

8. Goering RV, Shawar RM, Scangarella NE, O’Hara FP, Amrine-Madsen H, West JM, Dalessandro M, Becker JA, Walsh SL, Miller LA, van Horn SF, Thomas ES, Twynholm ME: Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global ICG-001 clinical trial clinical trials. J Clin Microbiol 2008, 46:2842–2847.PubMedCrossRef 9. Coombs G, Monecke S, Pearson JC, Tan H, Chew Y, Wilson L, Ehricht R, O’Brien FG, Christiansen KJ: Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol 2011, 11:215.PubMedCrossRef 10. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA: Gefitinib cost Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase. Cell 2001, 104:901–912.PubMedCrossRef 11. Aubry-Damon H, Soussy CJ, Courvalin

P: Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus . Antimicrob Agents Chemother 1998, 42:2590–2594.PubMed 12. Wichelhaus TA, Schafer V, Brade V, Böddinghaus B: Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 1999, 43:2813–2816.PubMed 13. O’Neill AJ, Huovinen T, Fishwick CWG, Chopra I: Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother 2006, 50:298–309.PubMedCrossRef 14. Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, Yoshikura H, Kuratsuji T, Kirikae T: Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother 2006, 12:47–50.PubMedCrossRef 15. Mick V, Domínguez MA, Tubau F, Liñares J, Pujol M, Martin R: Molecular characterization of resistance to rifampicin in an emerging hospital-associated methicillin-resistant Staphylococcus

Metformin cost aureus clone ST228, Spain. BMC Microbiol 2010, 10:68.PubMedCrossRef 16. Villar M, Marimón JM, García-Arenzana JM, de la Campa AG, Ferrándiz MJ, Pérez-Trallero E: Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples. J Antimicrob Chemother 2011, 66:997–1000.PubMedCrossRef 17. Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K: Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus . J Clin Microbiol 2011, 49:2680–2684.PubMedCrossRef 18. VassarStats: Website for Statistical Computation [http://​vassarstats.​net/​] 19. Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 1999, 41:95–98. 20. Codon Usage Database [http://​www.​kazusa.​or.